TICKERNOMICS Sign up
Last Update: 2024-03-28 02:12:49
MAXCYTE INC. ( MXCT ) https://maxcyte.com
4.34USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
MXCT
6.37%
SPY
32.74%
-25.81%
MXCT
SPY
92.93%
MXCT
0.00%
SPY
224.41%
MXCT
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
452.23
329.91
0.42
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-13.61
11.89
1.95
-10.66
0.00
-6.60
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-174.31
90.09
-148.70
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-7370.26
-21.40
0.00
Other Earnings and Cash Flow Stats:
MAXCYTE INC. ( MXCT ) Net Income TTM ($MM) is -27.86
MAXCYTE INC. ( MXCT ) Operating Income TTM ($MM) is -41.59
MAXCYTE INC. ( MXCT ) Owners' Earnings Annual ($MM) is 0.00
MAXCYTE INC. ( MXCT ) Current Price to Owners' Earnings ratio is 0.00
MAXCYTE INC. ( MXCT ) EBITDA TTM ($MM) is -37.84
MAXCYTE INC. ( MXCT ) EBITDA Margin is -148.70%
Capital Allocation:
MAXCYTE INC. ( MXCT ) has paid 0.00 dividends per share and bought back -2.259006 million shares in the past 12 months
MAXCYTE INC. ( MXCT ) has increased its debt by 2.648 million USD in the last 12 months
Capital Structure:
MAXCYTE INC. ( MXCT ) Interest-bearing Debt ($MM) as of last quarter is 18
MAXCYTE INC. ( MXCT ) Annual Working Capital Investments ($MM) are -24
MAXCYTE INC. ( MXCT ) Book Value ($MM) as of last quarter is 232
MAXCYTE INC. ( MXCT ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
MAXCYTE INC. ( MXCT ) has 46 million in cash on hand as of last quarter
MAXCYTE INC. ( MXCT ) has 17 million of liabilities due within 12 months, and long term debt 0 as of last quarter
MAXCYTE INC. ( MXCT ) has 103 common shares outstanding as of last quarter
MAXCYTE INC. ( MXCT ) has 0 million USD of preferred stock value
Academic Scores:
MAXCYTE INC. ( MXCT ) Altman Z-Score is 6.83 as of last quarter
MAXCYTE INC. ( MXCT ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
MAXCYTE INC. ( MXCT ) largest shareholder is Cadian Capital Management LP owning 5644898 shares at 24.50 ($MM) value
John Joseph Johnston(an insider) Sold 5000 shares of MAXCYTE INC. ( MXCT ) for the amount of $25600.00 on 2024-01-26
1.19% of MAXCYTE INC. ( MXCT ) is held by insiders, and 76.21% is held by institutions
MAXCYTE INC. ( MXCT ) went public on 2021-07-30
Other MAXCYTE INC. ( MXCT ) financial metrics:
FCF:-32.52
Unlevered Free Cash Flow:-5405.32
EPS:-0.43
Operating Margin:-174.31
Gross Profit Margin:90.09
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-19.39
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About MAXCYTE INC. ( MXCT ) :
MaxCyte, Inc., a global life sciences company, discovers, develops, and commercializes next-generation cell therapies. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.